725 related articles for article (PubMed ID: 28630042)
21. NADPH debt drives redox bankruptcy: SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation.
Liu X; Zhang Y; Zhuang L; Olszewski K; Gan B
Genes Dis; 2021 Nov; 8(6):731-745. PubMed ID: 34522704
[TBL] [Abstract][Full Text] [Related]
22. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
Habib E; Linher-Melville K; Lin HX; Singh G
Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
[TBL] [Abstract][Full Text] [Related]
23. Role of SLC7A11/xCT in Ovarian Cancer.
Fantone S; Piani F; Olivieri F; Rippo MR; Sirico A; Di Simone N; Marzioni D; Tossetta G
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203758
[TBL] [Abstract][Full Text] [Related]
24. SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties.
Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Aboody KS
Stem Cells Dev; 2017 Sep; 26(17):1236-1246. PubMed ID: 28610554
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of SLC7A11/xCT creates a vulnerability to selenocystine-induced cytotoxicity.
Tan SLW; Tan HM; Israeli E; Fatihah I; Ramachandran V; Ali SB; Goh SJA; Wee J; Tan AQL; Tam WL; Han W
Biochem J; 2023 Dec; 480(24):2045-2058. PubMed ID: 38078799
[TBL] [Abstract][Full Text] [Related]
26. SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells.
Yan Y; Teng H; Hang Q; Kondiparthi L; Lei G; Horbath A; Liu X; Mao C; Wu S; Zhuang L; James You M; Poyurovsky MV; Ma L; Olszewski K; Gan B
Nat Commun; 2023 Jun; 14(1):3673. PubMed ID: 37339981
[TBL] [Abstract][Full Text] [Related]
27. Glial Glutamate Transporter-Mediated Plasticity: System x
Dahlmanns M; Dahlmanns JK; Savaskan N; Steiner HH; Yakubov E
Front Biosci (Landmark Ed); 2023 Mar; 28(3):57. PubMed ID: 37005761
[TBL] [Abstract][Full Text] [Related]
28. Merlin/NF2 regulates SLC7A11/xCT expression and cell viability under glucose deprivation at high cell density in glioblastoma cells.
Yamaguchi I; Katoh H
J Biochem; 2024 Mar; 175(3):313-322. PubMed ID: 38102738
[TBL] [Abstract][Full Text] [Related]
29. Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance.
Lim JKM; Delaidelli A; Minaker SW; Zhang HF; Colovic M; Yang H; Negri GL; von Karstedt S; Lockwood WW; Schaffer P; Leprivier G; Sorensen PH
Proc Natl Acad Sci U S A; 2019 May; 116(19):9433-9442. PubMed ID: 31000598
[TBL] [Abstract][Full Text] [Related]
30. Cystine/glutamate antiporter xCT controls skeletal muscle glutathione redox, bioenergetics and differentiation.
Kanaan MN; Pileggi CA; Karam CY; Kennedy LS; Fong-McMaster C; Cuperlovic-Culf M; Harper ME
Redox Biol; 2024 Jul; 73():103213. PubMed ID: 38815331
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT.
Lien EC; Ghisolfi L; Geck RC; Asara JM; Toker A
Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259101
[TBL] [Abstract][Full Text] [Related]
32. Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
Okazaki S; Umene K; Yamasaki J; Suina K; Otsuki Y; Yoshikawa M; Minami Y; Masuko T; Kawaguchi S; Nakayama H; Banno K; Aoki D; Saya H; Nagano O
Cancer Sci; 2019 Nov; 110(11):3453-3463. PubMed ID: 31444923
[TBL] [Abstract][Full Text] [Related]
33. BAP1 links metabolic regulation of ferroptosis to tumour suppression.
Zhang Y; Shi J; Liu X; Feng L; Gong Z; Koppula P; Sirohi K; Li X; Wei Y; Lee H; Zhuang L; Chen G; Xiao ZD; Hung MC; Chen J; Huang P; Li W; Gan B
Nat Cell Biol; 2018 Oct; 20(10):1181-1192. PubMed ID: 30202049
[TBL] [Abstract][Full Text] [Related]
34. SLC7A11 negatively associates with mismatch repair gene expression and endows glioblastoma cells sensitive to radiation under low glucose conditions.
Hu N; Hu WH; Zhou SL; Yang Z; Liang WL; Yang RY; Li MH; Jing Z; Li ZA; Fu XD; Wang XJ
Neoplasma; 2021 Nov; 68(6):1147-1156. PubMed ID: 34427100
[TBL] [Abstract][Full Text] [Related]
35. Increased Expression of System xc- in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance.
Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Cassady K; Aboody KS
Mol Cancer Res; 2016 Dec; 14(12):1229-1242. PubMed ID: 27658422
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the effects of polyunsaturated fatty acids on transporter expressions using a PCR array: Induction of xCT/SLC7A11 in human placental BeWo cells.
Ono K; Furugen A; Kurosawa Y; Jinno N; Narumi K; Kobayashi M; Iseki K
Placenta; 2019 Jan; 75():34-41. PubMed ID: 30712664
[TBL] [Abstract][Full Text] [Related]
37. Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis.
Sehm T; Rauh M; Wiendieck K; Buchfelder M; Eyüpoglu IY; Savaskan NE
Oncotarget; 2016 Nov; 7(46):74630-74647. PubMed ID: 27612422
[TBL] [Abstract][Full Text] [Related]
38. High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma.
Sørensen MF; Heimisdóttir SB; Sørensen MD; Mellegaard CS; Wohlleben H; Kristensen BW; Beier CP
J Neurooncol; 2018 May; 138(1):49-53. PubMed ID: 29404978
[TBL] [Abstract][Full Text] [Related]
39. SLC7A11/ xCT is a target of miR-5096 and its restoration partially rescues miR-5096-mediated ferroptosis and anti-tumor effects in human breast cancer cells.
Yadav P; Sharma P; Sundaram S; Venkatraman G; Bera AK; Karunagaran D
Cancer Lett; 2021 Dec; 522():211-224. PubMed ID: 34571083
[TBL] [Abstract][Full Text] [Related]
40. The amino acid transporter SLC7A11-mediated crosstalk implicated in cancer therapy and the tumor microenvironment.
He J; Wang X; Chen K; Zhang M; Wang J
Biochem Pharmacol; 2022 Nov; 205():115241. PubMed ID: 36084707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
